𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Breast-conserving therapy for paget disease of the nipple : A prospective european organization for research and treatment of cancer study of 61 patients

✍ Scribed by Nina Bijker; Emiel J.T. Rutgers; Luc Duchateau; Johannes L. Peterse; Jean-Pierre Julien; Luigi Cataliotti; EORTC Breast Cancer Cooperative Group

Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
73 KB
Volume
91
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Interferon-Ξ± and chemohormonal therapy f
Interferon-Ξ± and chemohormonal therapy for patients with advanced melanoma : Final results of a Phase I-II study of the Cancer Biotherapy Research Group and the Mid-Atlantic Oncology Program
✍ James J. Stark; Robert O. Dillman; Richard Schulof; Michael C. Wiemann; Neil M. πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 86 KB πŸ‘ 1 views

## Background: The treatment of metastatic melanoma remains unsatisfactory despite encouraging results with biotherapy and combination chemotherapy. combining these two modalities may improve outcomes for such patients. ## Methods: Patients who were eligible for this study had metastatic melanoma

The provisional Paediatric Rheumatology
The provisional Paediatric Rheumatology International Trials Organisation/American College of Rheumatology/european League Against Rheumatism Disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: A prospective validation study
✍ Ruperto, Nicolino ;Ravelli, Angelo ;Pistorio, Angela ;Ferriani, Virginia ;Calvo, πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 120 KB πŸ‘ 2 views
A phase II study of gemcitabine in patie
A phase II study of gemcitabine in patients with malignant pleural mesothelioma
✍ Jan P. van Meerbeeck; Paul Baas; Channa Debruyne; Harry J. Groen; Chris Manegold πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 115 KB πŸ‘ 2 views

## BACKGROUND. Gemcitabine has shown activity in patients with less chemosensitive solid tumors. Phase II screening of novel drugs is an accepted method with which to investigate new therapies in malignant mesothelioma. The European Organization for Research and Treatment of Cancer-Lung Cancer Coo